About Us Services Careers FAQ Contact Us 0
Home Biotechnology Drug Discovery Service Market Size, Growth & Share | Forecast-2031 |
Drug Discovery Service Market

Drug Discovery Service Market Size, Share & Trends Analysis Report By Type (Pharmacokinetics, Drug Metabolism, Biology Services, Medicinal Chemistry, Others), By Process (Target Validation, Target Selection, Hit-To-Lead Identification, Candidate Validation, Lead Optimization, Others), By Drug Type (Biologics, Small Molecules), By Therapeutic Area (Neurology, Diabetes, Oncology, Respiratory Diseases, Cardiovascular Diseases, Others), By End-User (Hospital & Clinics, Pharmaceutical Companies, Biotechnology Companies, Research Institute) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRBI1301DR
Last Updated : December 27, 2022
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Drug Discovery Service Market Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Pharmacokinetics
        1. By Value
      3. Drug Metabolism
        1. By Value
      4. Biology Services
        1. By Value
      5. Medicinal Chemistry
        1. By Value
      6. Others
        1. By Value
    3. By Process
      1. Introduction
        1. Process By Value
      2. Target Validation
        1. By Value
      3. Target Selection
        1. By Value
      4. Hit-To-Lead Identification
        1. By Value
      5. Candidate Validation
        1. By Value
      6. Lead Optimization
        1. By Value
      7. Others
        1. By Value
    4. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Biologics
        1. By Value
      3. Small Molecules
        1. By Value
    5. By Therapeutic Area
      1. Introduction
        1. Therapeutic Area By Value
      2. Neurology
        1. By Value
      3. Diabetes
        1. By Value
      4. Oncology
        1. By Value
      5. Respiratory Diseases
        1. By Value
      6. Cardiovascular Diseases
        1. By Value
      7. Others
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital & Clinics
        1. By Value
      3. Pharmaceutical Companies
        1. By Value
      4. Biotechnology Companies
        1. By Value
      5. Research Institute
        1. By Value
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Pharmacokinetics
        1. By Value
      3. Drug Metabolism
        1. By Value
      4. Biology Services
        1. By Value
      5. Medicinal Chemistry
        1. By Value
      6. Others
        1. By Value
    3. By Process
      1. Introduction
        1. Process By Value
      2. Target Validation
        1. By Value
      3. Target Selection
        1. By Value
      4. Hit-To-Lead Identification
        1. By Value
      5. Candidate Validation
        1. By Value
      6. Lead Optimization
        1. By Value
      7. Others
        1. By Value
    4. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Biologics
        1. By Value
      3. Small Molecules
        1. By Value
    5. By Therapeutic Area
      1. Introduction
        1. Therapeutic Area By Value
      2. Neurology
        1. By Value
      3. Diabetes
        1. By Value
      4. Oncology
        1. By Value
      5. Respiratory Diseases
        1. By Value
      6. Cardiovascular Diseases
        1. By Value
      7. Others
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital & Clinics
        1. By Value
      3. Pharmaceutical Companies
        1. By Value
      4. Biotechnology Companies
        1. By Value
      5. Research Institute
        1. By Value
    7. U.S.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Pharmacokinetics
          1. By Value
        3. Drug Metabolism
          1. By Value
        4. Biology Services
          1. By Value
        5. Medicinal Chemistry
          1. By Value
        6. Others
          1. By Value
      2. By Process
        1. Introduction
          1. Process By Value
        2. Target Validation
          1. By Value
        3. Target Selection
          1. By Value
        4. Hit-To-Lead Identification
          1. By Value
        5. Candidate Validation
          1. By Value
        6. Lead Optimization
          1. By Value
        7. Others
          1. By Value
      3. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Biologics
          1. By Value
        3. Small Molecules
          1. By Value
      4. By Therapeutic Area
        1. Introduction
          1. Therapeutic Area By Value
        2. Neurology
          1. By Value
        3. Diabetes
          1. By Value
        4. Oncology
          1. By Value
        5. Respiratory Diseases
          1. By Value
        6. Cardiovascular Diseases
          1. By Value
        7. Others
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital & Clinics
          1. By Value
        3. Pharmaceutical Companies
          1. By Value
        4. Biotechnology Companies
          1. By Value
        5. Research Institute
          1. By Value
    8. Canada
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Pharmacokinetics
        1. By Value
      3. Drug Metabolism
        1. By Value
      4. Biology Services
        1. By Value
      5. Medicinal Chemistry
        1. By Value
      6. Others
        1. By Value
    3. By Process
      1. Introduction
        1. Process By Value
      2. Target Validation
        1. By Value
      3. Target Selection
        1. By Value
      4. Hit-To-Lead Identification
        1. By Value
      5. Candidate Validation
        1. By Value
      6. Lead Optimization
        1. By Value
      7. Others
        1. By Value
    4. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Biologics
        1. By Value
      3. Small Molecules
        1. By Value
    5. By Therapeutic Area
      1. Introduction
        1. Therapeutic Area By Value
      2. Neurology
        1. By Value
      3. Diabetes
        1. By Value
      4. Oncology
        1. By Value
      5. Respiratory Diseases
        1. By Value
      6. Cardiovascular Diseases
        1. By Value
      7. Others
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital & Clinics
        1. By Value
      3. Pharmaceutical Companies
        1. By Value
      4. Biotechnology Companies
        1. By Value
      5. Research Institute
        1. By Value
    7. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Pharmacokinetics
          1. By Value
        3. Drug Metabolism
          1. By Value
        4. Biology Services
          1. By Value
        5. Medicinal Chemistry
          1. By Value
        6. Others
          1. By Value
      2. By Process
        1. Introduction
          1. Process By Value
        2. Target Validation
          1. By Value
        3. Target Selection
          1. By Value
        4. Hit-To-Lead Identification
          1. By Value
        5. Candidate Validation
          1. By Value
        6. Lead Optimization
          1. By Value
        7. Others
          1. By Value
      3. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Biologics
          1. By Value
        3. Small Molecules
          1. By Value
      4. By Therapeutic Area
        1. Introduction
          1. Therapeutic Area By Value
        2. Neurology
          1. By Value
        3. Diabetes
          1. By Value
        4. Oncology
          1. By Value
        5. Respiratory Diseases
          1. By Value
        6. Cardiovascular Diseases
          1. By Value
        7. Others
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital & Clinics
          1. By Value
        3. Pharmaceutical Companies
          1. By Value
        4. Biotechnology Companies
          1. By Value
        5. Research Institute
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Pharmacokinetics
        1. By Value
      3. Drug Metabolism
        1. By Value
      4. Biology Services
        1. By Value
      5. Medicinal Chemistry
        1. By Value
      6. Others
        1. By Value
    3. By Process
      1. Introduction
        1. Process By Value
      2. Target Validation
        1. By Value
      3. Target Selection
        1. By Value
      4. Hit-To-Lead Identification
        1. By Value
      5. Candidate Validation
        1. By Value
      6. Lead Optimization
        1. By Value
      7. Others
        1. By Value
    4. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Biologics
        1. By Value
      3. Small Molecules
        1. By Value
    5. By Therapeutic Area
      1. Introduction
        1. Therapeutic Area By Value
      2. Neurology
        1. By Value
      3. Diabetes
        1. By Value
      4. Oncology
        1. By Value
      5. Respiratory Diseases
        1. By Value
      6. Cardiovascular Diseases
        1. By Value
      7. Others
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital & Clinics
        1. By Value
      3. Pharmaceutical Companies
        1. By Value
      4. Biotechnology Companies
        1. By Value
      5. Research Institute
        1. By Value
    7. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Pharmacokinetics
          1. By Value
        3. Drug Metabolism
          1. By Value
        4. Biology Services
          1. By Value
        5. Medicinal Chemistry
          1. By Value
        6. Others
          1. By Value
      2. By Process
        1. Introduction
          1. Process By Value
        2. Target Validation
          1. By Value
        3. Target Selection
          1. By Value
        4. Hit-To-Lead Identification
          1. By Value
        5. Candidate Validation
          1. By Value
        6. Lead Optimization
          1. By Value
        7. Others
          1. By Value
      3. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Biologics
          1. By Value
        3. Small Molecules
          1. By Value
      4. By Therapeutic Area
        1. Introduction
          1. Therapeutic Area By Value
        2. Neurology
          1. By Value
        3. Diabetes
          1. By Value
        4. Oncology
          1. By Value
        5. Respiratory Diseases
          1. By Value
        6. Cardiovascular Diseases
          1. By Value
        7. Others
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital & Clinics
          1. By Value
        3. Pharmaceutical Companies
          1. By Value
        4. Biotechnology Companies
          1. By Value
        5. Research Institute
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Pharmacokinetics
        1. By Value
      3. Drug Metabolism
        1. By Value
      4. Biology Services
        1. By Value
      5. Medicinal Chemistry
        1. By Value
      6. Others
        1. By Value
    3. By Process
      1. Introduction
        1. Process By Value
      2. Target Validation
        1. By Value
      3. Target Selection
        1. By Value
      4. Hit-To-Lead Identification
        1. By Value
      5. Candidate Validation
        1. By Value
      6. Lead Optimization
        1. By Value
      7. Others
        1. By Value
    4. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Biologics
        1. By Value
      3. Small Molecules
        1. By Value
    5. By Therapeutic Area
      1. Introduction
        1. Therapeutic Area By Value
      2. Neurology
        1. By Value
      3. Diabetes
        1. By Value
      4. Oncology
        1. By Value
      5. Respiratory Diseases
        1. By Value
      6. Cardiovascular Diseases
        1. By Value
      7. Others
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital & Clinics
        1. By Value
      3. Pharmaceutical Companies
        1. By Value
      4. Biotechnology Companies
        1. By Value
      5. Research Institute
        1. By Value
    7. UAE
      1. By Type
        1. Introduction
          1. Type By Value
        2. Pharmacokinetics
          1. By Value
        3. Drug Metabolism
          1. By Value
        4. Biology Services
          1. By Value
        5. Medicinal Chemistry
          1. By Value
        6. Others
          1. By Value
      2. By Process
        1. Introduction
          1. Process By Value
        2. Target Validation
          1. By Value
        3. Target Selection
          1. By Value
        4. Hit-To-Lead Identification
          1. By Value
        5. Candidate Validation
          1. By Value
        6. Lead Optimization
          1. By Value
        7. Others
          1. By Value
      3. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Biologics
          1. By Value
        3. Small Molecules
          1. By Value
      4. By Therapeutic Area
        1. Introduction
          1. Therapeutic Area By Value
        2. Neurology
          1. By Value
        3. Diabetes
          1. By Value
        4. Oncology
          1. By Value
        5. Respiratory Diseases
          1. By Value
        6. Cardiovascular Diseases
          1. By Value
        7. Others
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital & Clinics
          1. By Value
        3. Pharmaceutical Companies
          1. By Value
        4. Biotechnology Companies
          1. By Value
        5. Research Institute
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Pharmacokinetics
        1. By Value
      3. Drug Metabolism
        1. By Value
      4. Biology Services
        1. By Value
      5. Medicinal Chemistry
        1. By Value
      6. Others
        1. By Value
    3. By Process
      1. Introduction
        1. Process By Value
      2. Target Validation
        1. By Value
      3. Target Selection
        1. By Value
      4. Hit-To-Lead Identification
        1. By Value
      5. Candidate Validation
        1. By Value
      6. Lead Optimization
        1. By Value
      7. Others
        1. By Value
    4. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Biologics
        1. By Value
      3. Small Molecules
        1. By Value
    5. By Therapeutic Area
      1. Introduction
        1. Therapeutic Area By Value
      2. Neurology
        1. By Value
      3. Diabetes
        1. By Value
      4. Oncology
        1. By Value
      5. Respiratory Diseases
        1. By Value
      6. Cardiovascular Diseases
        1. By Value
      7. Others
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospital & Clinics
        1. By Value
      3. Pharmaceutical Companies
        1. By Value
      4. Biotechnology Companies
        1. By Value
      5. Research Institute
        1. By Value
    7. Brazil
      1. By Type
        1. Introduction
          1. Type By Value
        2. Pharmacokinetics
          1. By Value
        3. Drug Metabolism
          1. By Value
        4. Biology Services
          1. By Value
        5. Medicinal Chemistry
          1. By Value
        6. Others
          1. By Value
      2. By Process
        1. Introduction
          1. Process By Value
        2. Target Validation
          1. By Value
        3. Target Selection
          1. By Value
        4. Hit-To-Lead Identification
          1. By Value
        5. Candidate Validation
          1. By Value
        6. Lead Optimization
          1. By Value
        7. Others
          1. By Value
      3. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Biologics
          1. By Value
        3. Small Molecules
          1. By Value
      4. By Therapeutic Area
        1. Introduction
          1. Therapeutic Area By Value
        2. Neurology
          1. By Value
        3. Diabetes
          1. By Value
        4. Oncology
          1. By Value
        5. Respiratory Diseases
          1. By Value
        6. Cardiovascular Diseases
          1. By Value
        7. Others
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospital & Clinics
          1. By Value
        3. Pharmaceutical Companies
          1. By Value
        4. Biotechnology Companies
          1. By Value
        5. Research Institute
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Drug Discovery Service Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Thermo Fisher Scientific, Inc.(The U.S.)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Albany Molecular Research, Inc. (The U.S.)
    3. Charles River Laboratories International, Inc. (The U.S.)
    4. Evotec A.G. (Germany)
    5. Domainex (UK)
    6. GenScript Biotech Corporation (China)
    7. Laboratory Corporation of America Holdings (The U.S.)
    8. WuXi AppTec (China)
    9. Pharmaceutical Product Development, LLC (The U.S.)
    10. Jubilant Biosys Ltd. (India)
    11. Eurofins Scientific SE (Luxembourg)
    12. Piramal Enterprises Ltd. (India)
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Drug Discovery Market Size The global drug discovery market size was valued at USD 24.84 billion in 2024 and is projected to reach from USD 28.98 billion in 2025 to USD 62.10 billion by 2033, growing at a CAGR of 14.90% during the forecast peri
Buy Now
Global Report
Drug Discovery Outsourcing Market Size The global drug discovery outsourcing market size was valued at USD 3.29 billion in 2021 and is projected to reach an expected value of USD 6.37 billion by 2030 at a CAGR of 7.6% o
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.